Payment overview · 2025
General Payments
$56.43
3 reported records · 2 companies
Healthcare provider profile · identity verified
Imran A Mirza, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine|Critical Care Medicine · DEPTFORD, NJ · NPI 1376573204
Verified facts
What the public records show
CMS Open Payments records show Imran A Mirza, M.D. received $56.43 in general payments during 2025 across 3 reported records.
ABBVIE INC. accounted for 68.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 27 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Lumigan by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $38.71 | 68.6% | 2 | 2025 |
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $17.72 | 31.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $56.43 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $38.71 | 2 | 2025 |
Source payment records
|
|||||
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $17.72 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
27 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LUMIGAN open payments reported associated product |
CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548 |
Lumigan · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1302 | 261 |
| Eliquis | Apixaban | 734 | 101 |
| Gabapentin | Gabapentin | 717 | 148 |
| Amlodipine Besylate | Amlodipine Besylate | 662 | 122 |
| Tamsulosin Hcl | Tamsulosin Hcl | 509 | 97 |
| Pantoprazole Sodium | Pantoprazole Sodium | 508 | 131 |
| Furosemide | Furosemide | 500 | 106 |
| Sertraline Hcl | Sertraline Hcl | 400 | 80 |
| Trazodone Hcl | Trazodone Hcl | 395 | 84 |
| Metformin Hcl | Metformin Hcl | 385 | 81 |
| Mirtazapine | Mirtazapine | 372 | 75 |
| Levothyroxine Sodium | Levothyroxine Sodium | 360 | 82 |
| Metoprolol Tartrate | Metoprolol Tartrate | 354 | 86 |
| Oxycodone Hcl | Oxycodone Hcl | 317 | 72 |
| Hydralazine Hcl | Hydralazine Hcl | 312 | 58 |
| Metoprolol Succinate | Metoprolol Succinate | 308 | 78 |
| Divalproex Sodium | Divalproex Sodium | 306 | 45 |
| Lisinopril | Lisinopril | 300 | 64 |
| Losartan Potassium | Losartan Potassium | 296 | 60 |
| Clopidogrel | Clopidogrel Bisulfate | 284 | 65 |
| Carvedilol | Carvedilol | 262 | 53 |
| Escitalopram Oxalate | Escitalopram Oxalate | 252 | 46 |
| Quetiapine Fumarate | Quetiapine Fumarate | 251 | 40 |
| Potassium Chloride | Potassium Chloride | 231 | 52 |
| Buspirone Hcl | Buspirone Hcl | 201 | 44 |
| Xarelto | Rivaroxaban | 196 | 26 |
| Donepezil Hcl | Donepezil Hcl | 190 | 36 |
| Tramadol Hcl | Tramadol Hcl | 187 | 59 |
| Risperidone | Risperidone | 185 | 27 |
| Omeprazole | Omeprazole | 182 | 49 |
| Baclofen | Baclofen | 179 | 38 |
| Montelukast Sodium | Montelukast Sodium | 175 | 39 |
| Levetiracetam | Levetiracetam | 156 | 37 |
| Lorazepam | Lorazepam | 147 | 49 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 142 | 23 |
| Lactulose | Lactulose | 139 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 135 | 51 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 134 | 66 |
| Olanzapine | Olanzapine | 130 | 20 |
| Ondansetron Hcl | Ondansetron Hcl | 124 | 72 |
| Famotidine | Famotidine | 117 | 47 |
| Hydrochlorothiazide | Hydrochlorothiazide | 117 | 15 |
| Midodrine Hcl | Midodrine Hcl | 116 | 31 |
| Alprazolam | Alprazolam | 115 | 30 |
| Memantine Hcl | Memantine Hcl | 115 | 21 |
| Clonazepam | Clonazepam | 110 | 27 |
| Duloxetine Hcl | Duloxetine Hcl | 101 | 31 |
| Sodium Chloride | 0.9 % Sodium Chloride | 100 | 41 |
| Januvia | Sitagliptin Phosphate | 98 | 14 |
| Fluoxetine Hcl | Fluoxetine Hcl | 97 | 15 |
| Albuterol Sulfate | Albuterol Sulfate | 96 | 33 |
| Incruse Ellipta | Umeclidinium Bromide | 96 | 19 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 94 | 34 |
| Lacosamide | Lacosamide | 91 | 19 |
| Doxycycline Hyclate | Doxycycline Hyclate | 90 | 44 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 89 | 34 |
| Ibuprofen | Ibuprofen | 87 | 35 |
| Amiodarone Hcl | Amiodarone Hcl | 84 | 27 |
| Lamotrigine | Lamotrigine | 84 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 83 | 17 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 83 | 26 |
| Prednisone | Prednisone | 83 | 28 |
| Warfarin Sodium | Warfarin Sodium | 83 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 81 | 20 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 79 | 19 |
| Aripiprazole | Aripiprazole | 78 | 24 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 78 | 41 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 76 | 20 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 74 | 11 |
| Glimepiride | Glimepiride | 73 | 17 |
| Sucralfate | Sucralfate | 71 | 11 |
| Allopurinol | Allopurinol | 70 | 18 |
| Insulin Lispro | Insulin Lispro | 70 | 29 |
| Naproxen | Naproxen | 70 | 15 |
| Jardiance | Empagliflozin | 69 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 67 | 25 |
| Ezetimibe | Ezetimibe | 66 | 17 |
| Latanoprost | Latanoprost | 66 | 18 |
| Pregabalin | Pregabalin | 65 | 17 |
| Acetic Acid | Acetic Acid | 64 | 29 |
| Nifedipine Er | Nifedipine | 64 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 64 | 15 |
| Breo Ellipta | Fluticasone/Vilanterol | 63 | suppressed |
| Spironolactone | Spironolactone | 62 | 21 |
| Cephalexin | Cephalexin | 60 | 41 |
| Bupropion Xl | Bupropion Hcl | 59 | 11 |
| Lithium Carbonate | Lithium Carbonate | 57 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 57 | 16 |
| Alendronate Sodium | Alendronate Sodium | 56 | 11 |
| Fenofibrate | Fenofibrate | 56 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 56 | 15 |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 55 | suppressed |
| Glipizide | Glipizide | 53 | 11 |
| Topiramate | Topiramate | 53 | suppressed |
| Atenolol | Atenolol | 52 | suppressed |
| Simvastatin | Simvastatin | 50 | 14 |
| Ammonium Lactate | Ammonium Lactate | 49 | 32 |
| Benztropine Mesylate | Benztropine Mesylate | 49 | suppressed |
| Finasteride | Finasteride | 48 | 11 |
| Methenamine Hippurate | Methenamine Hippurate | 48 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 48 | suppressed |
| Digoxin | Digoxin | 47 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 47 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 46 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 45 | 15 |
| Clonidine Hcl | Clonidine Hcl | 44 | 13 |
| Nystatin | Nystatin | 44 | 24 |
| Dicyclomine Hcl | Dicyclomine Hcl | 43 | suppressed |
| Timolol Maleate | Timolol Maleate | 43 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 40 | 30 |
| Diclofenac Sodium | Diclofenac Sodium | 40 | 24 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 40 | 11 |
| Metformin Hcl Er | Metformin Hcl | 39 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 37 | 17 |
| Metoclopramide Hcl | Metoclopramide Hcl | 37 | 12 |
| Torsemide | Torsemide | 37 | 19 |
| Humalog | Insulin Lispro | 36 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 36 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 36 | 14 |
| Daptomycin | Daptomycin | 35 | suppressed |
| Meloxicam | Meloxicam | 35 | 12 |
| Mupirocin | Mupirocin | 34 | 23 |
| Farxiga | Dapagliflozin Propanediol | 33 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 33 | suppressed |
| Levofloxacin | Levofloxacin | 33 | 15 |
| Ventolin Hfa | Albuterol Sulfate | 33 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 32 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 32 | suppressed |
| Amoxicillin | Amoxicillin | 31 | 20 |
| Azithromycin | Azithromycin | 31 | 15 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 31 | 14 |
| Santyl | Collagenase Clostridium Hist. | 31 | 19 |
| Alogliptin | Alogliptin Benzoate | 30 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 30 | suppressed |
| Hydrocortisone | Hydrocortisone | 29 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 29 | 19 |
| Nitroglycerin | Nitroglycerin | 29 | 20 |
| Telmisartan | Telmisartan | 29 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 29 | 11 |
| Bumetanide | Bumetanide | 28 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 28 | 14 |
| Ketoconazole | Ketoconazole | 28 | 12 |
| Linzess | Linaclotide | 27 | suppressed |
| Haloperidol | Haloperidol | 26 | suppressed |
| Methimazole | Methimazole | 26 | suppressed |
| Budesonide | Budesonide | 25 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 25 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 25 | suppressed |
| Nyamyc | Nystatin | 25 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 25 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 25 | 16 |
| Enalapril Maleate | Enalapril Maleate | 24 | suppressed |
| Entresto | Sacubitril/Valsartan | 24 | 11 |
| Morphine Sulfate Er | Morphine Sulfate | 24 | suppressed |
| Tradjenta | Linagliptin | 24 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 23 | suppressed |
| Calcium Acetate | Calcium Acetate | 23 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 23 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 23 | 17 |
| Betamethasone Valerate | Betamethasone Valerate | 22 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 22 | 12 |
| Labetalol Hcl | Labetalol Hcl | 22 | suppressed |
| Meropenem | Meropenem | 22 | suppressed |
| Methocarbamol | Methocarbamol | 22 | 13 |
| Myrbetriq | Mirabegron | 22 | suppressed |
| Repaglinide | Repaglinide | 22 | suppressed |
| Restasis | Cyclosporine | 22 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 22 | 17 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 21 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 21 | suppressed |
| Methadone Hcl | Methadone Hcl | 21 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 21 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 21 | suppressed |
| Aptiom | Eslicarbazepine Acetate | 20 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 20 | suppressed |
| Calcitriol | Calcitriol | 20 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 20 | 12 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 20 | suppressed |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 20 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 20 | suppressed |
| Nystop | Nystatin | 20 | 13 |
| Propranolol Hcl | Propranolol Hcl | 20 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 20 | suppressed |
| Valsartan | Valsartan | 20 | 11 |
| Bupropion Hcl | Bupropion Hcl | 19 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 19 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 19 | suppressed |
| Pimozide | Pimozide | 19 | suppressed |
| Procrit | Epoetin Alfa | 19 | suppressed |
| Steglatro | Ertugliflozin Pidolate | 19 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 19 | suppressed |
| Zonisamide | Zonisamide | 19 | suppressed |
| Cilostazol | Cilostazol | 18 | suppressed |
| Lumigan | Bimatoprost | 18 | suppressed |
| Ozempic | Semaglutide | 18 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 18 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 17 | 11 |
| Clonidine | Clonidine | 17 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 17 | suppressed |
| Fentanyl | Fentanyl | 17 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 17 | suppressed |
| Lidocaine | Lidocaine | 17 | suppressed |
| Methylprednisolone | Methylprednisolone | 17 | 14 |
| Olanzapine Odt | Olanzapine | 17 | suppressed |
| Xtampza Er | Oxycodone Myristate | 17 | suppressed |
| Acamprosate Calcium | Acamprosate Calcium | 16 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 16 | suppressed |
| Colchicine | Colchicine | 16 | suppressed |
| Hydroxyurea | Hydroxyurea | 16 | suppressed |
| Loperamide | Loperamide Hcl | 16 | 12 |
| Nortriptyline Hcl | Nortriptyline Hcl | 16 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 15 | 15 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 15 | 15 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 15 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 15 | suppressed |
| Irbesartan | Irbesartan | 15 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 15 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 15 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 14 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 14 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 14 | suppressed |
| Trospium Chloride | Trospium Chloride | 14 | suppressed |
| Cefoxitin | Cefoxitin Sodium | 13 | suppressed |
| Chlorthalidone | Chlorthalidone | 13 | suppressed |
| Donepezil Hcl Odt | Donepezil Hcl | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | suppressed |
| Methotrexate | Methotrexate Sodium | 13 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 13 | suppressed |
| Novolog | Insulin Aspart | 13 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 13 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 12 | suppressed |
| Cyclosporine | Cyclosporine | 12 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 12 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 12 | suppressed |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 12 | suppressed |
| Tetrabenazine | Tetrabenazine | 12 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 12 | suppressed |
| Amikacin Sulfate | Amikacin Sulfate | 11 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 11 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Rivastigmine | Rivastigmine | 11 | suppressed |
| Scopolamine | Scopolamine | 11 | suppressed |
| Trulance | Plecanatide | 11 | suppressed |
| Zaleplon | Zaleplon | 11 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $56.43 · 3 records | ABBVIE INC. | NUPLAZID, VRAYLAR | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error